dashboard BOARD MEETING Peter Hansen and Hope Johnson 10-11 June - PowerPoint PPT Presentation

Gavi Alliance Strategy 2016-2020: Goal level indicators and disease dashboard BOARD MEETING Peter Hansen and Hope Johnson 10-11 June 2015, Geneva Reach every child www.gavi.org

Gavi, The Vaccine Alliance Strategy 2016-2020  < 5 mortality rate To save children’s lives and protect TBD Mission Empirical measures of health outcomes: Disease Aspiration  Future deaths averted people’s health by increasing 5-6 million  Hepatitis B dashboard 2020  Future DALYs averted >250 million  Rotavirus diarrhea equitable use of vaccines in lower  # of children vaccinated with GAVI support  Measles >300 million income countries  Vaccines sustained after transition…………….. 100%  Integrated: Foster integration of immunisation with other health interventions, harmonising support by the GAVI Alliance with other partners’  Country-led: Respond to and align with country demand, supporting national  Innovative: Foster and take to scale innovation in development models, financing priorities, budget processes and decision-making Principles instruments, public health approaches, immunisation-related technologies and delivery  Community-owned: Ensure engagement of communities to increase accountability science and sustain demand and impact  Collaborative: As a public private partnership, convene immunisation stakeholders and  Globally engaged: Contribute to the Global Vaccine Action plan, align with the post leverage the strengths of all Alliance partners through shared responsibility at both global 2015 global development priorities and implement the aid effectiveness principles and national level  Catalytic & sustainable: Provide support to generate long term sustainable results  Accountable: Maximise Alliance cooperation and performance through transparent including country self-financing of vaccines through the graduation process accountability mechanisms Increase effectiveness and Accelerate equitable Improve sustainability Shape markets Goals efficiency of immunisation 4 1 uptake and coverage of 2 3 of national immunisation 4 for vaccines and other delivery as an integrated part vaccines programmes immunisation products of strengthened health systems Increase coverage and equity of Contribute to improving integrated and Enhance national and sub-national Ensure adequate and secure supply of a a a a immunisation comprehensive immunisation programmes, political commitment to immunisation quality vaccines including fixed, outreach and b b b Support countries to introduce and Ensure appropriate allocation and Reduce prices of vaccines and other supplementary components Objectives scale up new vaccines management of national human and immunisation products to an b Support improvements in supply chains, financial resources to immunisation appropriate and sustainable level c Respond flexibly to the special health information systems, demand through legislative and budgetary needs of children in fragile c Incentivise development of suitable c generation and gender sensitive means countries c and quality vaccines and other approaches Prepare countries to sustain immunisation products b c Strengthen engagement of civil society, performance in immunisation after private sector and other partners in graduation immunisation     Reach of routine coverage : penta3 Supply chain DRAFT: rolling average Co-financing : % countries fulfilling co- Healthy market dynamics: TBD  Effective Vaccine Management scores financing commitments Adequate and uninterrupted supply : and measles first dose Goal-level indicators    Breadth of protection : average Data quality DRAFT: difference between Country investments in routine % vaccine markets where supply Gavi coverage across all supported administrative coverage and survey immunisation : % countries with meets demand   vaccines Access, demand & service delivery increasing investment in routine Reduction in price : Reduction in  Equity of coverage and barriers DRAFT: penta1 coverage and drop out immunisation per child weighted average price of fully   Integration DRAFT: increased oral Programmatic sustainability : % vaccinating a child with pentavalent, Distribution by :  geography rehydration coverage following rotavirus countries on track for successful pneumococcal and rotavirus vaccines   wealth quintiles vaccine introductions graduation Innovation : # vaccines and    education status of mothers Civil society & private sector DRAFT: % Strengthen institutional capacity for immunisation products with improved / / female caretakers of countries with civil society or private national decision-making, characteristics procured by Gavi  sector partners in national plans management & monitoring: TBD fragile state status A) Country leadership A) Country leadership (1) (1) Strengthen institutional capacity for national decision-making, programme management and monitoring Strengthen institutional capacity for national decision-making, programme management and monitoring Strategic enablers management & coordination (2) Support availability and use of quality data for country-level decision making management & coordination (2) Support availability and use of quality data for country-level decision making (1) Secure long-term predictable funding for GAVI Alliance programmes as a prerequisite for continued success B) Resource mobilisation (2) Harness the capacity of the private sector, including through innovative finance mechanisms and contributions from vaccine manufacturers (1) Strengthen national political and subnational commitment for immunisation C) Advocacy (2) Strengthen global political commitment for immunisation, health and development Support GAVI as a learning Alliance through (i) Effective routine programme monitoring and management and (ii) Regular evaluation of the Support GAVI as a learning Alliance through (i) Effective routine programme monitoring and management and (ii) Regular evaluation of the D) Monitoring & Evaluation D) Monitoring & Evaluation D) Monitoring & Evaluation relevance, effectiveness, impact, and efficiency of the GAVI Alliance’s investments to inform evidence -based policy development relevance, effectiveness, impact, and efficiency of the GAVI Alliance’s investments to inform evidence -based policy development 2

Aspiration 2020 Indicators <5 mortality rate TBD Future deaths averted 5 – 6 Million Future DALYs averted > 250 Million Number of children vaccinated > 300 Million with Gavi support New indicator recommended: % of countries sustaining delivery of all recommended 100% vaccines in their routine programmes after transition Gavi Board meeting 10 – 11 June 2015 3

Disease Dashboard Recommended Indicators • Number of countries that have <2% hepatitis B surface Hepatitis B antigen (HBsAg) prevalence among children <5 years of age • Median % (and interquartile range) of acute gastroenteritis hospitalisations positive for rotavirus among children less Diarrhoea than one year of age among countries with any surveillance site meeting inclusion criteria • Number of countries reporting an annual incidence of less Measles than 5 measles cases per million population. Gavi Board meeting 10 – 11 June 2015 4

SG1 Six indicators recommended in three areas Reach of routine 1. Coverage with 3rd dose of pentavalent vaccine coverage 2. Coverage with first dose of measles vaccine Breadth of 3. Average coverage across all Gavi supported protection vaccines delivered through routine systems 4. Geographic distribution • % of countries with all districts having ≥80% penta3 vaccination coverage Equity of 5. Wealth quintile distribution • % of countries in which penta3 coverage in poorest quintile is within coverage and 10 percentage points of penta3 coverage in wealthiest quintile barriers to 6. Distribution by education status of mother/female immunisation caretakers • % of countries in which penta3 coverage among children whose mothers/caretakers received no education is within 20 percentage points of coverage among children whose mothers/caretakers have received secondary education or higher Gavi Board meeting 10 – 11 June 2015 5

SG2 Supply chain Data quality Indicators under development: Access, demand To be presented to and service PPC in October and delivery Board in December Integration Civil Society Gavi Board meeting 10 – 11 June 2015 6

SG3 Recommended Indicators Co-financing • % of countries fulfilling co-financing commitments Country • % of countries with increasing investment in routine investments in immunisation per child relative to 2015 baseline (with routine average amount invested and average % of increase over baseline tracked) immunisation Programmatic • % of countries on track for successful graduation sustainability • Supplement with fourth indicator of strengthening institutional capacity for national decision making, programme management and monitoring Gavi Board meeting 10 – 11 June 2015 7